A J Kovatich Selected Research

A J Kovatich Research Topics

Disease

9	Neoplasms (Cancer) 03/2016 - 01/2000
5	Carcinoma (Carcinomatosis) 06/2000 - 01/2000
2	Breast Neoplasms (Breast Cancer) 03/2016 - 04/2014
1	Lymphoma (Lymphomas) 04/2014
1	Transitional Cell Carcinoma 10/2001
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 05/2001
1	Fever (Fevers) 05/2001
1	Panniculitis 05/2001
1	Cytopenia 05/2001
1	Dermatitis 05/2001
1	Colorectal Neoplasms (Colorectal Cancer) 12/2000
1	Cystadenoma 06/2000
1	Atypical Squamous Cells of the Cervix 05/2000
1	Papillomavirus Infections 05/2000
1	Extramammary Paget Disease (Paget Disease, Extramammary) 04/2000
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2000
1	Stomach Neoplasms (Stomach Cancer) 01/2000
1	Adenocarcinoma 01/2000

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 03/2016 - 06/2000
2	Estrogen ReceptorsIBA 03/2016 - 04/2000
2	Keratin-5 (Keratin 5)IBA 03/2016 - 04/2014
2	Progesterone FDA LinkGeneric 04/2014 - 04/2000
2	Hormones (Hormone)IBA 04/2014 - 04/2000
2	ParaffinIBA 04/2000 - 01/2000
1	Messenger RNA (mRNA)IBA 03/2016
1	GlucocorticoidsIBA 03/2016
1	SteroidsIBA 03/2016
1	PromegestoneIBA 04/2014
1	Progesterone CongenersIBA 04/2014
1	Estrogen Receptor Modulators (Antiestrogen)IBA 04/2014
1	Phenobarbital (Luminal)FDA Link 04/2014
1	Progestins (Progestagens)IBA 04/2014
1	ProlactinIBA 04/2014
1	Keratin-20 (Cytokeratin 20)IBA 10/2001
1	Protein Isoforms (Isoforms)IBA 10/2001
1	Biological ProductsIBA 10/2001
1	MucinsIBA 05/2001
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2001
1	Prednisone (Sone)FDA LinkGeneric 05/2001
1	Cell Cycle ProteinsIBA 12/2000
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2000
1	Androgen Antagonists (Antiandrogens)IBA 06/2000
1	Ethanol (Ethyl Alcohol)IBA 05/2000
1	Biomarkers (Surrogate Marker)IBA 05/2000
1	Cyclin EIBA 05/2000
1	Estrogens (Estrogen)FDA Link 04/2000
1	Androgen Receptors (Androgen Receptor)IBA 04/2000
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2000
1	Steroid Receptors (Steroid Receptor)IBA 04/2000
1	Formaldehyde (Formol)FDA Link 04/2000
1	AndrogensIBA 04/2000
1	Environmental CarcinogensIBA 02/2000
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2000
1	Tumor Biomarkers (Tumor Markers)IBA 01/2000
1	DO-7 monoclonal antibodyIBA 01/2000
1	fragile histidine triad proteinIBA 01/2000
1	Indicators and Reagents (Reagents)IBA 01/2000
1	CarcinogensIBA 01/2000

Therapy/Procedure

5	Therapeutics 03/2016 - 06/2000
1	Drug Therapy (Chemotherapy) 05/2001